1861-1873
Original Article
Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity
James W. Wells, Chris J. Cowled, David Darling, Barbara-Ann Guinn and Farzin Farzaneh, et al.
1875-1883
Original Article
Open AccessGene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo
Cor H. J. Lamers, Sabine C. L. Langeveld, Corrien M. Groot-van Ruijven, Reno Debets and Stefan Sleijfer, et al.
1885-1895
Original Article
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides
Morgan G. Mathieu, Ashley J. Knights, Graham Pawelec, Catherine L. Riley and Dorothee Wernet, et al.
1897-1910
Original Article
Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity
Chie Kudo-Saito, Charlie T. Garnett, Elizabeth K. Wansley, Jeffrey Schlom and James W. Hodge
1911-1920
Original Article
Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells
Freddy Tita-Nwa, Gerhard Moldenhauer, Markus Herbst, Christian Kleist and Anthony D. Ho, et al.
1921-1930
Original Article
A polyvalent vaccine for high-risk prostate patients: “are more antigens better?”
Susan F. Slovin, Govind Ragupathi, Celina Fernandez, Meghan Diani and Matthew P. Jefferson, et al.
1931-1943
Original Article
Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
Lisa H. Butterfield, Antoni Ribas, Douglas M. Potter and James S. Economou
1945-1954
Original Article
Specific CD8+ T cell responses to HLA-A2 restricted MAGE-A3 p271–279 peptide in hepatocellular carcinoma patients without vaccination
Hua-Gang Zhang, Hong-Song Chen, Ji-Run Peng, Xiao-Ying Shang and Jun Zhang, et al.
1955-1965
Original Article
Robust anti-tumor immunity and memory in Rag-1-deficient mice following adoptive transfer of cytokine-primed splenocytes and tumor CD80 expression
Priyadarshini L. Ganesan, Stephen I. Alexander, Debbie Watson, Grant J. Logan and Geoff Y. Zhang, et al.
1967-1977
Original Article
Open AccessAn ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer
Francesca Milano, Agnieszka M. Rygiel, Navtej Buttar, Jacques J. G. H. M. Bergman and Carine Sondermeijer, et al.
1979-1991
Original Article
Low TCR avidity and lack of tumor cell recognition in CD8+ T cells primed with the CEA-analogue CAP1-6D peptide
Manuela Iero, Paola Squarcina, Pedro Romero, Philippe Guillaume and Elisa Scarselli, et al.
1993-2001
Original Article
Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma–carcinoma sequence
Guanglin Cui, Aping Yuan, Rasmus Goll, Trine Olsen and Anne Husebekk, et al.
2003-2016
Original Article
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors
Ayala Tamir, Ernesto Basagila, Arash Kagahzian, Long Jiao and Steen Jensen, et al.
2017
Erratum
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors
Ayala Tamir, Ernesto Basaglia, Arash Kagahzian, Long Jiao and Steen Jensen, et al.